AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 JUN 11 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in India have identified a mycobacterial protein that could be used as the basis for a tuberculosis vaccine.
"The search to identify Mycobacterium tuberculosis antigens capable of conferring protective immunity against tuberculosis has received a boost owing to the resurgence of tuberculosis over the past two decades," explained Priti Kumar and colleagues at the Indian Institute of Science and the National Tuberculosis Institute in Bangalore. "It has long been recognized that lymphoid cells are required for protection against M. tuberculosis."
The pathogen's Apa protein had a protective effect in animals as part of a prime-boost DNA vaccine regimen, Kumar and coauthors reported.
Peripheral blood cells from purified protein derivative (PPD)-positive individuals responded strongly to Apa exposure, with both lymphoproliferative activity and gamma interferon (IFN-gamma) secretion, the researchers said. The antigen provoked Th1 cytokine production from both cytotoxic and helper T cells.
A DNA vaccine based on Apa provided only modest protection in a guinea pig model of M. tuberculosis infection, test results showed. However, DNA vaccine priming followed by boosting ...
Source: HighBeam Research, Mycobacterial Apa protein immunogenic.